Reference
Marquez Fernandez E, et al. Use of vandetanib in medullary thyroid cancer. International Journal of Clinical Pharmacy 38: 587 abstr. PT048, No. 6, Apr 2016. Available from: URL: http://doi.org/10.1007/s11096-015-0240-y [abstract] - Spain
Rights and permissions
About this article
Cite this article
Vandetanib. Reactions Weekly 1607, 420 (2016). https://doi.org/10.1007/s40278-016-18994-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-18994-0